Table 6.
Factor | HR (95% CI) | p value |
---|---|---|
Combination with bevacizumab | 0.37 (0.16–0.84) | .018 |
Age (IQR: 53.25–73) | 1.46 (0.77–2.80) | .248 |
Modified Glasgow prognostic score | 1.30 (0.49–3.44) | .599 |
Abbreviations: CI, confidence interval; HR, hazard ratio; IQR, interquartile range.